2seventy bio Inc (TSVT) Q3 2024 Earnings Call Highlights: Strong Abecma Growth and Strategic ... [Yahoo! Finance]
2seventy bio, Inc. (TSVT)
Company Research
Source: Yahoo! Finance
Collaboration Arrangement Revenue: Approximately $11 million related to the collaboration with Bristol Myers Squibb. GAAP Operating Expenses Reduction: $10 million or 24% reduction versus the prior quarter; $140 million or 52% year-to-date reduction versus the same period last year. Net Cash Spend for 2024: Expected to be in the range of $40 to $60 million. Cash Runway: Expected to extend beyond 2027. Warning! GuruFocus has detected 7 Warning Signs with TSVT. Release Date: November 12, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript 2seventy bio Inc ( NASDAQ:TSVT ) successfully completed the sale of its oncology and autoimmune R&D pipeline to Regeneron, streamlining operations. The company received FDA approval for Abecma in the third-line setting, expanding its availability to more multiple myeloma patients. Third quarter US revenues for Abecma grew by 42% over the previous quarter, indicating strong market p
Show less
Read more
Impact Snapshot
Event Time:
TSVT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TSVT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TSVT alerts
High impacting 2seventy bio, Inc. news events
Weekly update
A roundup of the hottest topics
TSVT
News
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVT Accesswire
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVTAccesswire
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVTAccesswire
- 2seventy bio Reports Third Quarter Financial Results and Recent Operational ProgressBusiness Wire
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVTPR Newswire
TSVT
Earnings
- 11/12/24 - Miss
TSVT
Sec Filings
- 11/20/24 - Form 4
- 11/18/24 - Form 144
- 11/12/24 - Form 10-Q
- TSVT's page on the SEC website